Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial
| Image |  |
|---|---|
| Description | scientific article published on 15 May 2017 |
| Author/s |
author: Brian Porter |
| Publication date | May 15, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |